Allstate to Report Q2 Earnings: Can Auto Brand Strength Save the Day?

Allstate is forecast to report Q2 2025 EPS of $3.36, a 108.7% year-over-year increase, and revenues of $17.16 billion, up 8.5%, driven by an expected rise in auto underwriting income to $484.7 million and an improved combined ratio of 94.99%. These gains are anticipated to be partially offset by a projected 44.3% year-over-year decrease in Health and Benefits net income and over 6% higher total costs and expenses. While Allstate has historically surpassed earnings estimates, Zacks' model does not conclusively predict an earnings beat for this quarter.

Analysis

Allstate (ALL) is approaching its Q2 2025 earnings report with strong top-line and bottom-line consensus estimates, but notable underlying risks. Projections indicate a significant year-over-year earnings jump of 108.7% to $3.36 per share, with revenues expected to increase 8.5% to $17.16 billion. This growth is primarily driven by the anticipated recovery in the Auto segment, where underwriting income is forecast to reach $484.7 million, supported by an improved combined ratio of 94.99%. Further tailwinds include a projected 14.5% year-over-year growth in net investment income and a 14.7% rise in adjusted net income from Protection Services. However, these positive factors are tempered by significant headwinds. The Allstate Health and Benefits unit's adjusted net income is expected to plummet by 44.3% year-over-year, and total costs and expenses are projected to rise by over 6%. Critically, despite a strong track record of beating estimates with an average surprise of 134.9% over the last four quarters, a proprietary model with a negative Earnings ESP of -4.91% does not predict a beat this quarter, creating a cautious and mixed outlook.

Key Decisions for Investors

• Investors should weigh the strong consensus growth forecasts, particularly in the auto insurance segment, against the material risks posed by a projected 44.3% decline in the Health and Benefits unit and a 6% rise in total expenses.
• Given the conflicting signals between strong historical earnings beats and a proprietary model that now predicts a miss (Earnings ESP of -4.91%), it may be prudent to consider hedging or trimming positions ahead of the earnings release on July 30th.
• Focus on the reported combined ratio and management's commentary on expense control, as these metrics will be critical in determining if the company can overcome cost pressures and the sharp downturn in its Health and Benefits segment to meet the high earnings expectations.